Korsana Biosciences, Inc. Common Stock
KRSA
17 hedge funds and large institutions have $932K invested in Korsana Biosciences, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.32% less ownership
Funds ownership: 14.1% → 13.78% (-0.32%)
6% less funds holding
Funds holding: 18 → 17 (-1)
24% less capital invested
Capital invested by funds: $1.23M → $932K (-$299K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.42K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$86 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$34.2K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$589 |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$92 |
KRSA Hedge Fund Activity: Q1 2025 in Review
17 of the 7,473 institutional investors tracked by Wall St. Rank reported a position in Korsana Biosciences, Inc. Common Stock (KRSA) for Q1 2025, worth a combined $932K — down 24% from $1.23M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of KRSA and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, adding an estimated $1.42K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $34.2K sold.
- 17 institutional investors held Korsana Biosciences, Inc. Common Stock (KRSA) as of Q1 2025, down from 18 in Q4 2024.
- Funds reported $932K of Korsana Biosciences, Inc. Common Stock stock for Q1 2025, down 24% quarter-over-quarter.
- 0 funds opened new Korsana Biosciences, Inc. Common Stock positions in Q1 2025 and 1 closed out, a net change of -1 holder.
- The largest Korsana Biosciences, Inc. Common Stock buyer in Q1 2025 was UBS Group, an estimated $1.42K added.
- The largest Korsana Biosciences, Inc. Common Stock seller in Q1 2025 was Renaissance Technologies, an estimated $34.2K sold.
Based on aggregated 13F filings for Q1 2025.